Effects of Prednisolone Administration on Clock Gene Expression and Indices of Circadian Rhythms in Healthy Human Males
- 15 October 2025
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (4) , 993-1003
Abstract
Objective: To investigate the impact of glucocorticoid (GC) exposure on clock gene expression in human skeletal muscle and fat, circadian variations in peripheral interstitial glucose levels, blood pressure, total and bioactive GC levels, and sleep quality. Methods: This randomized double-blind crossover trial included 10 healthy male individuals aged 18 to 34 years. Prednisolone (12.5 mg)/placebo was given in random order twice daily at 07:00 hours and 19:00 hours for 5 days with a 6-week washout. Results: Prednisolone suppressed endogenous circadian cortisol levels while mean ± SD area under the curve (AUC) serum free GC activity (µmol/L*min) increased 4.5-fold (121.9 ± 30.8 [prednisolone] vs 27.2 ± 8.3 [placebo], P < .001). Prednisolone significantly abrogated the normal approximately 3-fold morning:evening variation in mRNA expression of 4 clock genes—BMAL1, NPAS2, PER3, and REV-ERB-β—in both adipose tissue and skeletal muscle. Prednisolone also increased nocturnal levels of interstitial glucose 67% (95% CI 36%-97%, P < .001) more than diurnal levels. Prednisolone increased mean ± SD nocturnal systolic blood pressure (mmHg) (123 ± 14 [prednisolone] vs 116 ± 7 [placebo], P = .05) and reduced mean ± SD sleep efficiency (%) (84% ± 4% [prednisolone] vs 87% ± 5% [placebo], P = .04) Conclusions: (1) Prednisolone abrogates the temporal pattern of clock gene expression in human skeletal muscle and adipose tissue. (2) This is accompanied by perturbations of circadian variations in interstitial glucose levels, blood pressure, as well as sleep quality. (3) We hypothesize that adverse effects of high-dose prednisolone treatment are partly mediated by disrupted clocks in metabolic tissues.Keywords
Funding Information
- Aarhus University
- Steno Diabetes Center Aarhus
- Chastine McKinney Moller Foundation (L-2023-00207)
- Novo Nordisk Foundation (NNF20OC0063280)
- German Research Foundation (OS-353-10/1)
This publication has 59 references indexed in Scilit:
- Highly Responsive Bioassay for Quantification of GlucocorticoidsAnalytical Chemistry, 2024
- Effects of short-term prednisolone treatment on indices of lipolysis and lipase signaling in abdominal adipose tissue in healthy humansMetabolism, 2019
- Circadian System and Glucose Metabolism: Implications for Physiology and DiseaseTrends in Endocrinology & Metabolism, 2016
- Meta-Review: Adverse Effects of Inhaled Corticosteroids Relevant to Older PatientsDrugs, 2014
- Prevalence rates of work organization characteristics among workers in the U.S.: Data from the 2010 National Health Interview SurveyAmerican Journal of Industrial Medicine, 2012
- PER2 Controls Lipid Metabolism by Direct Regulation of PPARγCell Metabolism, 2010
- The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clockCell Metabolism, 2006
- Population‐based assessment of adverse events associated with long‐term glucocorticoid useArthritis Care & Research, 2006
- The Human and Mouse Period1 Genes: Five Well-Conserved E-Boxes Additively Contribute to the Enhancement of mPer1 TranscriptionGenomics, 2000
- Diurnal variation in prednisolone kineticsClinical Pharmacology & Therapeutics, 1983